U.S. Digital Therapeutics Market Updates : to Grow at a CAGR of 19.2% from 2020 to 2027

According to a new report published by Allied Market Research, titled, "U.S. Digital Therapeutics Market by Application, Product, and Sales Channel: Opportunity Analysis and Industry Forecast, 2020-2027,"the U.S. digital therapeutics market was valued at $1.16 billion in 2019 and is expected to reach $5.08 billion by 2027 with a CAGR of 19.2% from 2020 to 2027. The diabetes segment accounted more than one-fifth of the total market share in 2019.

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝑪𝒐𝒑𝒚 𝒐𝒇 𝑹𝒆𝒑𝒐𝒓𝒕- https://www.alliedmarketresearch.com/request-sample/7066

𝑻𝒉𝒆 𝒔𝒐𝒇𝒕𝒘𝒂𝒓𝒆 𝒔𝒆𝒈𝒎𝒆𝒏𝒕 𝒕𝒐 𝒎𝒂𝒊𝒏𝒕𝒂𝒊𝒏 𝒊𝒕𝒔 𝒅𝒐𝒎𝒊𝒏𝒂𝒏𝒄𝒆 𝒃𝒚 2027
In 2019, the software segment played a pivotal role, constituting over two-thirds of the U.S. digital therapeutics market. It is projected to sustain its dominance in revenue share through 2027, with an anticipated highest Compound Annual Growth Rate (CAGR) of 20.3% during the forecast period. This remarkable growth is driven by the growing demand for cost-effective healthcare solutions and the presence of innovative software and apps with advanced features designed to assist individuals in maintaining good health and accessing appropriate treatment. The study also delves into the analysis of the devices segment.

𝑻𝒉𝒆 𝒃𝒖𝒔𝒊𝒏𝒆𝒔𝒔 𝒕𝒐 𝒃𝒖𝒔𝒊𝒏𝒆𝒔𝒔 𝒔𝒆𝒈𝒎𝒆𝒏𝒕 𝒕𝒐 𝒄𝒐𝒏𝒕𝒊𝒏𝒖𝒆 𝒊𝒕𝒔 𝒉𝒊𝒈𝒉𝒆𝒔𝒕 𝒄𝒐𝒏𝒕𝒓𝒊𝒃𝒖𝒕𝒊𝒐𝒏 𝒃𝒚 2027

In 2019, the business-to-business segment played a significant role, accounting for nearly two-thirds of the U.S. digital therapeutics market, and this dominance is expected to persist throughout the forecast period. The sustained contribution can be attributed to the increasing number of industry players offering favorable reimbursement policies to employees through their employers in the U.S. On the other hand, the business-to-consumer segment is anticipated to exhibit the highest Compound Annual Growth Rate (CAGR) of 19.8% from 2020 to 2027. This growth is driven by the ease of accessibility and availability of software and smart devices, coupled with a rising demand for digital therapeutic products among both patients and caregivers.

𝑻𝒉𝒆 𝒅𝒊𝒂𝒃𝒆𝒕𝒆𝒔 𝒔𝒆𝒈𝒎𝒆𝒏𝒕 𝒕𝒐 𝒎𝒂𝒊𝒏𝒕𝒂𝒊𝒏 𝒊𝒕𝒔 𝒅𝒐𝒎𝒊𝒏𝒂𝒏𝒕 𝒑𝒐𝒔𝒊𝒕𝒊𝒐𝒏 𝒕𝒉𝒓𝒐𝒖𝒈𝒉𝒐𝒖𝒕 𝒕𝒉𝒆 𝒇𝒐𝒓𝒆𝒄𝒂𝒔𝒕 𝒑𝒆𝒓𝒊𝒐𝒅

In 2019, the diabetes segment emerged as the leading application, capturing over one-fourth of the U.S. digital therapeutics market, and it is anticipated to sustain this dominant position in the forecast period. This prevalence is linked to the widespread occurrence of diabetes and the availability of cost-effective treatment alternatives. Conversely, the obesity segment is poised to experience the most rapid Compound Annual Growth Rate (CAGR) of 22.1% from 2020 to 2027. This growth is driven by the increasing number of overweight individuals and the convenient accessibility of digital therapeutics software applications aimed at assisting patients in maintaining proper diets and monitoring physical activities.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 𝐚𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/7066

𝑳𝒆𝒂𝒅𝒊𝒏𝒈 𝒎𝒂𝒓𝒌𝒆𝒕 𝒑𝒍𝒂𝒚𝒆𝒓𝒔
2MORROW, Inc.
Fitbit, Inc. (Twine Health, Inc.)
Livongo Health, Inc.
Medtronic Plc.
Omada Health, Inc.
Pear Therapeutics, Inc.
Proteus Digital Health, Inc.
Resmed, Inc. (Propeller Health)
Voluntis, Inc.
Welldoc, Inc.

𝑶𝒖𝒓 𝑴𝒂𝒓𝒌𝒆𝒕 𝑹𝒆𝒔𝒆𝒂𝒓𝒄𝒉 𝑺𝒐𝒍𝒖𝒕𝒊𝒐𝒏 𝑷𝒓𝒐𝒗𝒊𝒅𝒆𝒔 𝒀𝒐𝒖 𝑨𝒏𝒔𝒘𝒆𝒓 𝒕𝒐 𝑩𝒆𝒍𝒐𝒘 𝑴𝒆𝒏𝒕𝒊𝒐𝒏𝒆𝒅 𝑸𝒖𝒆𝒔𝒕𝒊𝒐𝒏:
Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2019?
How will each segment grow over the forecast period and how much revenue will these segments account for in 2027?
Which region has more opportunities?

𝑲𝒏𝒐𝒘 𝑴𝒐𝒓𝒆- https://www.alliedmarketresearch.com/us-digital-therapeutics-market-A06701

𝑶𝒕𝒉𝒆𝒓 𝑻𝒓𝒆𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒑𝒐𝒓𝒕𝒔 𝒊𝒏 𝑳𝒊𝒇𝒆 𝑺𝒄𝒊𝒆𝒏𝒄𝒆 𝑫𝒐𝒎𝒂𝒊𝒏
𝑪𝒍𝒆𝒂𝒏𝒓𝒐𝒐𝒎 𝑪𝒐𝒏𝒔𝒖𝒎𝒂𝒃𝒍𝒆𝒔 𝒎𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/cleanroom-consumables-market-A10926

𝑴𝒚𝒂𝒔𝒕𝒉𝒆𝒏𝒊𝒂 𝑮𝒓𝒂𝒗𝒊𝒔 𝑻𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/myasthenia-gravis-treatment-market-A11194

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.